Topcon announces investment in Senseye to advance mental health diagnostics
Topcon Healthcare a global leader in digital health and ocular data solutions, has announced a strategic investment in Senseye, a U.S.-based developer of a mental health diagnostic platform powered by ocular biomarkers, marking the company’s first investment in technology for mental health and neuropsychiatry. Leveraging the eye as a non-invasive window into the brain, Senseye…



